New single-dose oral treatment for human African trypanosomiasis (sleeping sickness)
First combined COVID-19 and influenza vaccine for people 50 years and older
Summary of opinion: Scemblix, 26/02/2026 Positive
Summary of opinion: Stelara, 26/02/2026 Positive
Summary of opinion: Dupixent, 26/02/2026 Positive
Summary of opinion: Keytruda, 26/02/2026 Positive
Info sheet - Orphan medicines in the EU
New medicine to treat paediatric low-grade glioma
Human medicines European public assessment report (EPAR): Flucelvax Tetra, influenza vaccine (surface antigen, inactivated, prepared in cell cultures), Date of authorisation: 12/12/2018, Revision: 17, Status: Withdrawn
Human medicines European public assessment report (EPAR): Taltz, ixekizumab, Date of authorisation: 25/04/2016, Revision: 20, Status: Authorised